Advertisement
Screener

AMICUS THERAPEUTICS, INC. Operating Lease Cost

AMICUS THERAPEUTICS, INC. Operating Lease Cost

AMICUS THERAPEUTICS, INC. reported Operating Lease Cost of $6.70 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-20.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:OperatingLeaseCost · last filed 2026-02-20

  • AMICUS THERAPEUTICS, INC. operating lease, cost for the quarter ending 2019-12-31 was $1.40M.
  • AMICUS THERAPEUTICS, INC. operating lease, cost for the quarter ending 2019-09-30 was $1.10M.
  • AMICUS THERAPEUTICS, INC. operating lease, cost for the quarter ending 2019-06-30 was $1.00M.
  • AMICUS THERAPEUTICS, INC. operating lease, cost for the quarter ending 2019-03-31 was $1.40M.
  • AMICUS THERAPEUTICS, INC. operating lease, cost for fiscal 2025 was $6.70M, a 0.00% change from fiscal 2024.
  • AMICUS THERAPEUTICS, INC. operating lease, cost for fiscal 2024 was $6.70M, a 29.47% decline from fiscal 2023.
  • AMICUS THERAPEUTICS, INC. operating lease, cost for fiscal 2023 was $9.50M, a 14.46% increase from fiscal 2022.
  • AMICUS THERAPEUTICS, INC. operating lease, cost for fiscal 2022 was $8.30M, a 1.19% decline from fiscal 2021.
Period endOperating Lease, Cost 3 monthOperating Lease, Cost 6 monthOperating Lease, Cost 9 monthOperating Lease, Cost 12 month
2025-12-31$6.70M
10-K · filed 2026-02-20
2024-12-31$6.70M
10-K · filed 2026-02-20
2023-12-31$9.50M
10-K · filed 2025-02-19
2022-12-31$8.30M
10-K · filed 2024-02-28
2021-12-31$8.40M
10-K · filed 2023-03-01
2020-12-31$9.60M
10-K · filed 2022-02-24
2019-12-31$1.40M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01
$2.50M
derived: sum of 2 quarters · filed 2021-03-01
$3.50M
derived: sum of 3 quarters · filed 2021-03-01
$4.90M
10-K · filed 2021-03-01
2019-09-30$1.10M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12
$2.10M
derived: sum of 2 quarters · filed 2019-11-12
$3.50M
10-Q · filed 2019-11-12
2019-06-30$1.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08
$2.40M
10-Q · filed 2019-08-08
2019-03-31$1.40M
10-Q · filed 2019-05-09